Cas:356062-62-9 2-[(1E,3Z)-3-(3-Butyl-1,1-dimethyl-1,3-dihydro-2H-benzo[e]indol-2 -ylidene)-1-propen-1-yl]-1,1,3-trimethyl-1H-benzo[e]indolium hexa fluorophosphate manufacturer & supplier

Chemical Name:2-[(1E,3Z)-3-(3-Butyl-1,1-dimethyl-1,3-dihydro-2H-benzo[e]indol-2 -ylidene)-1-propen-1-yl]-1,1,3-trimethyl-1H-benzo[e]indolium hexa fluorophosphate

CAS.NO:356062-62-9

Synonyms:2-[(1E,3Z)-3-(3-Butyl-1,1-dimethyl-1,3-dihydro-2H-benzo[e]indol-2 -ylidene)-1-propen-1-yl]-1,1,3-trimethyl-1H-benzo[e]indolium hexa fluorophosphate

Molecular Formula:C₃₆H₃₉F₆N₂P

Molecular Weight:644.67200

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:19.84000

Exact Mass:644.27600

LogP:12.44320

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-[(1E,3Z)-3-(3-Butyl-1,1-dimethyl-1,3-dihydro-2H-benzo[e]indol-2 -ylidene)-1-propen-1-yl]-1,1,3-trimethyl-1H-benzo[e]indolium hexa fluorophosphate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-[(1E,3Z)-3-(3-Butyl-1,1-dimethyl-1,3-dihydro-2H-benzo[e]indol-2 -ylidene)-1-propen-1-yl]-1,1,3-trimethyl-1H-benzo[e]indolium hexa fluorophosphate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-[(1E,3Z)-3-(3-Butyl-1,1-dimethyl-1,3-dihydro-2H-benzo[e]indol-2 -ylidene)-1-propen-1-yl]-1,1,3-trimethyl-1H-benzo[e]indolium hexa fluorophosphate Use and application,2-[(1E,3Z)-3-(3-Butyl-1,1-dimethyl-1,3-dihydro-2H-benzo[e]indol-2 -ylidene)-1-propen-1-yl]-1,1,3-trimethyl-1H-benzo[e]indolium hexa fluorophosphate technical grade,usp/ep/jp grade.

Related News: As a global-risk medical practice transforming care of the neediest populations, our centers are located in underserved neighborhoods,” notes Faisel Syed, M.D., ChenMed National Director of Primary Care. dithiocyanatomercury,λ(sup)1(/sup)-selanylformonitrile,nickel manufacturers The Plexxikon patents are for compounds that reduce cancer cell growth by blocking V600E mutated BRAF. Patents were filed as early as 2005. N-(2,4-dichlorophenethyl)-6-(4-hydroxypyridin-3-yl)-3-oxo-2,3-dihydropyridazine-4-carboxamide suppliers The Ballina facility was first established in 1974 and was acquired by Charles River in 2002. Over the years it has added to its capabilities offering a comprehensive package of GMP services in support of recombinant biologics, vaccines, cell and gene therapies, biosimilars, and medical devices. Charles River now employs 230 people at two facilities in Ireland: the site in Ballina Co. Mayo which focuses on biologics testing, and a site in Dublin, established in 2017, which serves as the EMEA and APAC headquarters for the Company’s Microbial Solutions division. 1,2-Propanediol, 3-[(10,13-dimethyltetradecyl)oxy]- vendor & factory.